Literature DB >> 19332975

Multimodality treatment for invasive pituitary adenomas.

Mark Hornyak1, William T Couldwell.   

Abstract

Most pituitary adenomas are slow-growing, benign tumors that do not exhibit aggressive behavior but instead grow by expansion. The majority of these adenomas can be treated successfully with transsphenoidal resection. However, more than one-third of adenomas are invasive, making complete surgical resection without unacceptable neurological deficits difficult. These more complicated adenomas require multimodal treatment and long-term follow-up for continued favorable outcomes. Initial surgical resection is indicated for decompression of the optic apparatus or cytoreduction before adjuvant therapy, even when gross total resection is not anticipated. Medical therapy is an option for most endocrinologically active adenomas, but nonfunctioning and functional adenomas that do not respond to medical therapy require a multidisciplinary approach. Radiation is often beneficial and can be delivered either as fractionated therapy or in a single dose. Conformal dose planning can be used in most cases to maximize therapeutic benefits. This article reviews the evaluation and treatment of invasive pituitary adenomas and discusses promising new therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332975     DOI: 10.3810/pgm.2009.03.1989

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  Endoscopic endonasal surgery for recurrent pituitary tumors: technical challenges to the surgical approach.

Authors:  Bobby A Tajudeen; Jagmeet Mundi; Jeffrey D Suh; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-13

2.  MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro.

Authors:  Kai Zhou; Yan-Dong Fan; Peng-Fei Wu; Serick Duysenbi; Zhao-Hai Feng; Guo-Jia Du; Ting-Rong Zhang
Journal:  Onco Targets Ther       Date:  2017-03-16       Impact factor: 4.147

3.  O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis.

Authors:  Congxin Dai; Bowen Sun; Xiaohai Liu; Xinjie Bao; Ming Feng; Yong Yao; Junji Wei; Kan Deng; Chengxian Yang; Xueyuan Li; Wenbin Ma; Renzhi Wang
Journal:  Oncotarget       Date:  2017-03-21

4.  Refractory pituitary adenoma: a novel classification for pituitary tumors.

Authors:  Congxin Dai; Ming Feng; Xiaohai Liu; Sihai Ma; Bowen Sun; Xinjie Bao; Yong Yao; Kan Deng; Yu Wang; Bing Xing; Wei Lian; Dingrong Zhong; Wenbin Ma; Renzhi Wang
Journal:  Oncotarget       Date:  2016-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.